Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
ESMO Open|June 25, 2019
New emerging targets in cancer immunotherapy: the role of LAG3Hannah Christina Puhr, Aysegül Ilhan-MutluBiomarkers in Medicine|April 4, 2013
Circulating biomarkers of CNS tumors: an updateAysegül Ilhan-Mutlu, Ludwig Wagner, Matthias PreusserCancers|September 28, 2021
Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?Hannah Christina Puhr, Matthias Preusser, Aysegül Ilhan-MutluCancers|February 5, 2020
New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?Hannah Christina Puhr, Matthias Preusser, Gerald Prager, et al.BMC Nephrology|December 15, 2015
NephroCheck data compared to serum creatinine in various clinical settingsSahra Pajenda, Aysegül Ilhan-Mutlu, Matthias Preusser, et al.Biomarkers in Medicine|March 27, 2015
Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancerAysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, et al.Cancers|March 29, 2023
Recent Advances in the Systemic Treatment of Localized Gastroesophageal CancerHannah Christina Puhr, Thorsten J Reiter, Matthias Preusser, et al.Cancer Investigation|August 16, 2012
Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patientsAysegül Ilhan-Mutlu, Ludwig Wagner, Adelheid Wöhrer, et al.Cancer Investigation|October 16, 2012
Blood alterations preceding clinical manifestation of glioblastomaAysegül Ilhan-Mutlu, Ludwig Wagner, Adelheid Wöhrer, et al.Cancer Investigation|June 5, 2014
Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumorsSebastian F Schoppmann, Gerda Ricken, Aysegül Ilhan-Mutlu, et al.Pageof 5